IA Trial Radar

Découvrons ensemble les essais cliniques avec Chugai Pharmaceutical en tant que promoteur principal ou collaborateur.

Je peux vous aider à comprendre votre état de santé, les traitements ou à trouver des essais cliniques près de chez vous.
Notre outil de recherche ne prend en charge que l'anglais. Pour la recherche et la discussion dans d'autres langues, utilisez l'IA Trial Radar ci-dessus ou sélectionnez les filtres de condition médicale et de lieu ci-dessous.
11 essais cliniques
 
Mots clés
Atezolizumab
×
 
Groupe d'âge
Adulte
×
 
Titre de l'étude
Statut
Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC (INDUCE) NCT06793553
En recrutement
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors NCT05907980
En recrutement
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) (SKYSCRAPER-14) NCT05904886
Actif, ne recrute pas
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 NCT05867121
Actif, ne recrute pas
A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma NCT05022927
Actif, ne recrute pas
The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) NCT04818983
Terminé
A Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer (AMBITION) NCT04732598
Actif, ne recrute pas
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) NCT04501497
Terminé
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment (CONTACT-03) NCT04338269
InterrompuRésultats publiés
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer (IMpassion050) NCT03726879
TerminéRésultats publiés
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL) NCT03645330
Terminé